 |
COMPANY | PRODUCT | APPLICATION | NEWS | PRESS
| |
|
June 2009 - Markus Jaquemar contributes international sales know how! Mag. Markus Jaquemar (46) joins Anagnostics Bioanalysis and contributes his international experience in marketing and sales. Markus, a biologist (University Vienna), was previously responsible for the global marketing of the life science portfolio of Agilent Technologies, a life science giant with 20,000 employees. There he served a 4.5 years term. January 2009 - tecnet capital and PP Capital join to finance market build-up! Two renowned Austrian early-stage investors have joined Anagnostics. tecnet capital and PPCapital fundings will be mainly invested into the market build-up.In the next one and a half years Anagnostics' focus will be serving markets in Germany, Switzerland and Austria. May 2008 - New production site in operation End of April we completed the installation and start-up of our new production facility in Linz.In a first step we have expanded our production capacity to more than 300 hybcells per day. We are using cutting-edge technology to assure first class and constant quality. As we have implemented a new production concept, we are now well prepared for future increase in demand - for "standardized" hybcells as well as for "customized" hybcells. March 2008 - Visit our lectures - get insights! We invite you to learn more about our hybcell technology, our company and application possibilities. On 11th March we give a short lecture about our approach of "methylation arrays" in the ZMF (Zentrum für Medizinische Forschung) in Graz. No registration required. On 13th March we are presenting during a workshop of our partner, Scienion AG, in Innsbruck. Registration required, please, download form below and send to Scienion. |
© ANAGNOSTICS 2009 |